Efficacy and Tolerance of Oral Minocycline Combined with Photobiomodulation Therapy for Rosacea: An Evaluator-blinded Randomized, Controlled Clinical Trial.

Photodermatology, Photoimmunology & PhotomedicineEarly View LETTER Efficacy and tolerance of Oral minocycline combined with photobiomodulation therapy for rosacea: An evaluator-blinded randomized, controlled clinical trial Yaoxi Su, Yaoxi Su Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaSearch for more papers by this authorShuwei Wu, Shuwei Wu Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaSearch for more papers by this authorLian Wang, Lian Wang Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaSearch for more papers by this authorBensen Sun, Bensen Sun Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaSearch for more papers by this authorXian Jiang, Corresponding Author Xian Jiang [email protected] Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China Correspondence Xian Jiang, Department of Dermatology, West China Hospital, Sichuan University, No.37 Guoxue Alley, Wuhou District, Chengdu City, Sichuan Province, 610041, China. Email: [email protected]Search for more papers by this author Yaoxi Su, Yaoxi Su Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaSearch for more papers by this authorShuwei Wu, Shuwei Wu Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaSearch for more papers by this authorLian Wang, Lian Wang Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaSearch for more papers by this authorBensen Sun, Bensen Sun Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, ChinaSearch for more papers by this authorXian Jiang, Corresponding Author Xian Jiang [email protected] Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China Correspondence Xian Jiang, Department of Dermatology, West China Hospital, Sichuan University, No.37 Guoxue Alley, Wuhou District, Chengdu City, Sichuan Province, 610041, China. Email: [email protected]Search for more papers by this author First published: 24 February 2023 https://doi.org/10.1111/phpp.12869 Yaoxi Su and Shuwei Wu should be considered joint first author. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. REFERENCES 1Juliandri J, Wang X, Liu Z, Zhang J, Xu Y, Yuan C. Global rosacea treatment guidelines and expert consensus points: the differences. J Cosmet Dermatol. 2019; 18(4): 960- 965. 2Falcone D, Uzunbajakava NE, Van Abeelen F, et al. Effects of blue light on inflammation and skin barrier recovery following acute perturbation. Pilot study results in healthy human subjects. Photodermatol Photoimmunol Photomed. 2018; 34(3): 184- 193. 3Fan L, Yin R, Lan T, Hamblin MR. Photodynamic therapy for rosacea in Chinese patients. Photodiagnosis Photodyn Ther. 2018; 24: 82- 87. 4Finlay AY, Khan GK. Dermatology life quality index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994; 19(3): 210- 216. 5Nicholson K, Abramova L, Chren M-M, Yeung J, Chon SY, Chen SC. A pilot quality-of-life instrument for acne rosacea. J Am Acad Dermatol. 2007; 57(2): 213- 221. 6Wu S, Su Y, Wang L, Sun B, Jiang X. The effects of photobiomodulation therapy on inflammatory mediators, immune infiltration, and angiogenesis in a mouse model of rosacea. Ann Transl Med. 2022; 10(15): 831. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation